GB:VAL Stock Latest News
Company AnnouncementsValiRx sees value boost from Ambrose’s AM-Pharma acquisition4w ago
Company AnnouncementsValiRx tightens operations and bolsters cash as it refocuses pipeline and portfolio2M ago
Company AnnouncementsValiRx bolsters Cytolytix cancer IP with new European patent and delivery platform filing3M ago
Company AnnouncementsValiRx AGM Backs Strategy as Board Changes and Large Warrant Issue Follow4M ago
Company AnnouncementsValiRx tightens focus and cuts costs as auditors flag going-concern risk5M ago
Company AnnouncementsValiRx Ends Dundee Evaluation After Cancer Asset Fails Licensing Criteria5M agoCompany AnnouncementsValiRx fast-tracks RNA helicase deal with McGill and plans Canadian spin-out5M ago
Company AnnouncementsValiRx Bolsters Cytolytix IP with New European Patent and Oncolytic Platform Filings5M ago
Company AnnouncementsValiRx Raises £1.16m in Oversubscribed Retail and Placing Fundraise6M ago
Company AnnouncementsValiRx Extends £1.15m Fundraise with UK Retail Share Offer and Attached Warrants6M ago
Company AnnouncementsValiRx launches discounted £1.155m raise to fund IP expansion and animal health push6M ago
Company AnnouncementsValiRx updates registered office as it advances oncology and women’s health focus7M agoCompany AnnouncementsValiRx trims costs and expands oncology pipeline with new human and veterinary initiatives7M ago
Company AnnouncementsValiRx gains oncology spotlight with digital twin data and expanding scientific footprint8M ago
Company AnnouncementsValiRx CEO Increases Stake with 1 Million-Share Purchase8M ago
Company AnnouncementsValiRx launches veterinary oncology arm to tap fast-growing animal cancer market8M ago
Company AnnouncementsValiRx Issues 80,000 New Shares Following Warrant Exercise10M ago
Company AnnouncementsValiRx Strikes RNA Helicase Deal with McGill and IRICoR Under Asset-Focused Funding Model10M ago
Company AnnouncementsValiRx Strikes RNA Helicase Inhibitor Deal with McGill and IRICoR to Drive Asset-Level Growth10M agoCompany AnnouncementsValiRx Advances with New Equity and Warrant Issuance Post-General Meeting12M ago
Company AnnouncementsValiRx PLC Announces Fundraising to Boost Cancer and Women’s Health Research1y ago



